This paper is in the following e-collection/theme issue:

Patient-Reported Outcome Measures (PROMs) (232) Adoption and Change Management of eHealth Systems (462) Innovations and Technology in Cancer Care (292) Participatory Medicine & E-Patients (578) Emotional, Social, Psychological Support for Cancer (145) Electronic/Mobile Data Capture, Internet-based Survey & Research Methodology (597)

Published on in Vol 22 , No 12 (2020) :December

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/18655, first published .
Digital Monitoring and Management of Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Treated With Cancer Immunotherapy and Its Impact on Quality of Clinical Care: Interview and Survey Study Among Health Care Professionals and Patients

Digital Monitoring and Management of Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Treated With Cancer Immunotherapy and Its Impact on Quality of Clinical Care: Interview and Survey Study Among Health Care Professionals and Patients

Digital Monitoring and Management of Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Treated With Cancer Immunotherapy and Its Impact on Quality of Clinical Care: Interview and Survey Study Among Health Care Professionals and Patients

Authors of this article:

Oliver Schmalz 1 Author Orcid Image ;   Christine Jacob 2, 3 Author Orcid Image ;   Johannes Ammann 4 Author Orcid Image ;   Blasius Liss 1 Author Orcid Image ;   Sanna Iivanainen 5 Author Orcid Image ;   Manuel Kammermann 6 Author Orcid Image ;   Jussi Koivunen 5 Author Orcid Image ;   Alexander Klein 4 Author Orcid Image ;   Razvan Andrei Popescu 7 Author Orcid Image
Article Authors Cited by (11) Tweetations (12) Metrics
Oliver Schmalz 1 * , MD ;   Christine Jacob 2, 3 * , MSc, PhD ;   Johannes Ammann 4 * , MSc, PhD ;   Blasius Liss 1 , MD ;   Sanna Iivanainen 5 , MD, PhD ;   Manuel Kammermann 6 , MSc ;   Jussi Koivunen 5 , MD, PhD ;   Alexander Klein 4 , MSc ;   Razvan Andrei Popescu 7 , MD

1 Department of Haematology , Oncology and Palliative Care , Helios Universitätsklinikum Wuppertal , Wuppertal , DE

2 The Faculty of Business and Law , Anglia Ruskin University , Cambridge , GB

3 School of Business , University of Applied Sciences Northwestern Switzerland , Brugg , CH

4 Medical Affairs (Personalised Healthcare and Patient Access) , F Hoffmann-La Roche Ltd , Basel , CH

5 Department of Oncology and Radiotherapy , Medical Research Center Oulu , Oulu University Hospital , Oulu , FI

6 Arcondis AG , Reinach , CH

7 Tumor Zentrum Aarau , Hirslanden Klinik Aarau , Aarau , CH

*these authors contributed equally

Corresponding Author:

  • Johannes Ammann , MSc, PhD
  • Medical Affairs (Personalised Healthcare and Patient Access)
  • F Hoffmann-La Roche Ltd
  • Grenzacherstrasse 124
  • Basel
  • CH
  • Phone: 41 792 921 758
  • Email: johannes.ammann@roche.com